Skip to main content

CON-TGO91-169 - Baxter Healthcare Pty Ltd

Product names
  • AUST R 19471 - BAXTER 0.224% POTASSIUM CHLORIDE and 0.18% SODIUM CHLORIDE and 4% GLUCOSE 1000 mL injection BP bag AHB1224
  • AUST R 48514 - BAXTER 0.15% POTASSIUM CHLORIDE and 0.18% SODIUM CHLORIDE AND 4% GLUCOSE 1000 mL injection BP bag AHB1704
  • AUST R 228340 - Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.45% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6024)
  • AUST R 228339 - Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.9% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6066)
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 28 February 2021.
Non-compliance with standard

The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.

Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines

Help us improve the Therapeutic Goods Administration site